Competing interests The authors declare no competing interests and also H.H
Currently, human clinical trials havent yet been established within the peer-reviewed literature. At present, most of the published evidence regarding this peptide falls within the first two categories
For example, one study in chronic insomniac patients used intravenous DSIP at 25 nmol/kg and found higher sleep efficiency, shorter sleep latency
These are people with slowed regeneration, a tendency toward dense scarring, or pronounced age-related skin changes
These include: Molecular interactions between receptors Cell signalling pathways Pharmacokinetics Metabolism Human clinical trials under strict control Biomarker reactions Site-specific effects The developments in the field of peptide chemistry might lead to enhanced molecular stability, selectivity for receptors, and analytical techniques